MYOMO, INC. (MYO)
Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their ability to perform daily activities. These devices aim to restore function for both adult and adolescent patients suffering from various neurological conditions, including stroke, spinal cord injury, traumatic brain injury, and brachial plexus injuries. Myomo distributes its innovative solutions through a network that includes orthotics and prosthetics providers, rehabilitation hospitals, the Veterans Health Administration, and additional distributors. Established in 2004, Myomo, Inc. maintains its corporate headquarters in Boston, Massachusetts.
Sector: Orthopedic, Prosthetic & Surgical Appliances & Supplies
Industry: Medical - Devices
Myomo, Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 39.87M shares outstanding
USMyomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States.
The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.
Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders.
The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
Leadership
Heather C. Getz
Director
Joseph M. Manko, Jr.
Director
Milton M. Morris
Director
Paul R. Gudonis
President, Chief Executive Officer & Chairman
Employees
184
Country
US
Sector
Healthcare
Website
myomo.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
 HENRY DAVID A | Chief Financial Officer | Grant/Award | 51.3K | -- | Oct 13, 2026 |
 GUDONIS PAUL R | Chief Executive Officer | Grant/Award | 71.3K | -- | Oct 13, 2026 |
 Kovelman Harry | Chief Medical Officer | Grant/Award | 32.5K | -- | Oct 13, 2026 |
| HENRY DAVID A | Chief Financial Officer | Automatic Sell | 3.1K | $4.3K | Oct 12, 2026 |
 McClure Mary-Katherine Hale | Chief Commericial Officer | Grant/Award | 275.0K | -- | Oct 12, 2026 |
| GUDONIS PAUL R | Chief Executive Officer | Grant/Award | 8.4K | -- | Oct 9, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
Rosalind Advisors, Inc. · net of 13F· joint filing· may incl. warrants· filed Sep 2026 | 7.4M | 9.9% as filed | 13G |
Rosalind Advisors, Inc. | 3.6M | 9.1% | 13F |
Horton Capital Partners Fund, LP · joint filing· may incl. warrants· reaffirmed Form 4 Jun 2026 | 2.3M | 5.8% | 13D |
VANGUARD CAPITAL MANAGEMENT LLC | 1.6M | 4.1% | 13F |
 GUDONIS PAUL R Chief Executive Officer, Director | 1.5M | 3.8% | FORM 4 |
AQR CAPITAL MANAGEMENT LLC | 928.3K | 2.3% | 13F |
 KIRK THOMAS F Director | 772.6K | 1.9% | FORM 4 |
Jefferies Financial Group Inc. | 704.3K | 1.8% | 13F |
JANE STREET GROUP, LLC | 596.4K | 1.5% | 13F |
 HENRY DAVID A Chief Financial Officer | 549.9K | 1.4% | FORM 4 |
Insiders
- HENRY DAVID AChief Financial Officer
- GUDONIS PAUL RChief Executive Officer
- Kovelman HarryChief Medical Officer
- McClure Mary-Katherine HaleChief Commericial Officer
- Morris Milton MayoDirector
- Mitchell MicahChief Commercial Officer
- FEBBO WILLIAM JDirector
- Crowley Thomas Aloysius Jr.Director
- KIRK THOMAS FDirector
- Manko Joseph M. Jr.Director
based on 39.87M shares outstanding
US30d Avg
245.22K
60d Avg
316.08K
90d Avg
479.40K